InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Farley Chele Chiavacci. Director active across 2 companies, notably CONDUIT PHARMACEUTICALS INC.. Aggregated, 6 disclosures have been logged. Activity tracked since 18 November 2024. The latest transaction was disclosed on 19 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Farley Chele Chiavacci is a declarant linked to CONDUIT PHARMACEUTICALS INC. and CDT Equity Inc. as Director. The record contains 6 filings in total, and across the sampled recent filings held, the period runs from 2023-09-26 to 2026-02-23, with the dominant transaction nature shown as Attribution.